Skip to main content
SpringerLink
Log in

Splanchnic vein thrombosis: clinical presentation, risk factors and treatment

  • IM - Review
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

The term splanchnic vein thrombosis encompasses Budd-Chiari syndrome (BCS), extrahepatic portal vein obstruction (EHPVO), and mesenteric vein thrombosis; the simultaneous involvement of additional regions is frequent, and clinical presentations and risk factors may be shared. The annual incidence of BCS and isolated mesenteric vein thrombosis is less than one per million individuals, while the incidence of EHPVO is about four per million; autopsy studies, however, suggest higher numbers. Current advances in non-invasive vascular imaging allow for the identification of chronic or asymptomatic forms. Risk factors can be local or systemic. A local precipitating factor is rare in BCS, while it is common in patients with portal vein thrombosis. Chronic myeloproliferative neoplasms (MPN) are the leading systemic cause of splanchnic vein thrombosis, and are diagnosed in half the BCS patients and one-third of the EHPVO patients. The molecular marker JAK2 V617F is detectable in a large majority of patients with overt MPN, and up to 40% of patients without overt MPN. Inherited thrombophilia is present in at least one-third of the patients, and the factor V Leiden or the prothrombin G20210A mutations are the most common mutations found in BCS or EHPVO patients, respectively. Multiple factors are present in approximately one-third of the patients with BCS and two-thirds of the patients with portal vein thrombosis. Immediate anticoagulation with heparin is used to treat patients acutely. Upon clinical deterioration, catheter-directed thrombolysis or transjugular intrahepatic portosystemic shunt is used in conjunction with anticoagulation. Long-term oral anticoagulation with vitamin K-antagonists (VKA) is recommended in all BCS patients, and in the patients with a permanent prothrombotic state associated with an unprovoked EHPVO. In patients with an unprovoked EHPVO and no prothrombotic conditions, or in those with a provoked EHPVO, anticoagulant treatment is recommended for a minimum of 3–6 months.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC, European Group for the Study of Vascular Disorders of the Liver (2003) Budd-Chiari syndrome: a review by an expert panel. J Hepatol 38:364–371

    Article  PubMed  Google Scholar 

  2. Sarin SK, Sollano JD, Chawla YK, Amarapurkar D, Hamid S, Hashizume M, Jafri W, Kumar A, Kudo M, Lesmana LA, Sharma BC, Shiha G, de Janaka Silva H, Members of the APASL Working Party on Portal Hypertension (2006) Consensus on extra-hepatic portal vein obstruction. Liver Int 26:512–519

    Article  PubMed  Google Scholar 

  3. Valla D (2004) Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West. J Gastroenterol Hepatol 19:204–211

    Article  Google Scholar 

  4. Almdal TP, Sorensen TI (1991) Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver. Hepatology 13:650–655

    Article  CAS  PubMed  Google Scholar 

  5. Rajani R, Melin T, Björnsson E, Broomé U, Sangfelt P, Danielsson A, Gustavsson A, Grip O, Svensson H, Lööf L, Wallerstedt S, Almer SH (2009) Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival—an 18-year experience. Liver Int 29:253–259

    Article  PubMed  Google Scholar 

  6. Eapen CE, Mammen T, Moses V, Shyamkumar NK (2007) Changing profile of Budd-Chiari syndrome in India. Indian J Gastroenterol 26:77–81

    CAS  PubMed  Google Scholar 

  7. Ogren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH (2006) Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23, 796 consecutive autopsies. World J Gastroenterol 12:2115–2119

    PubMed  Google Scholar 

  8. Acosta S, Alhadad A, Svensson P, Ekberg O (2008) Epidemiology, risk and prognostic factors in mesenteric venous thrombosis. Br J Surg 95:1245–1251

    Article  CAS  PubMed  Google Scholar 

  9. Acosta S, Ogren M, Sternby NH, Bergqvist D, Björck M (2005) Mesenteric venous thrombosis with transmural intestinal infarction: a population-based study. J Vasc Surg 41:59–63

    Article  PubMed  Google Scholar 

  10. Dentali F, Ageno W, Witt D, Malato A, Clark N, Garcia D, McCool K, Siragusa S, Dyke S, Crowther M, WARPED consortium (2009) Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study. Thromb Haemost 102:501–504

    CAS  PubMed  Google Scholar 

  11. Darvish Murad S, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, van Hoek B, Hansen BE, Rosendaal FR, Janssen HL (2004) Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 39:500–508

    Article  Google Scholar 

  12. Mentha G, Giostra E, Majno PE, Bechstein WO, Neuhaus P, O’Grady J, Praseedom RK, Burroughs AK, Le Treut YP, Kirkegaard P, Rogiers X, Ericzon BG, Hockerstedt K, Adam R, Klempnauer J (2006) Liver transplantation for Budd-Chiari syndrome: a European study on 248 patients from 51 centres. J Hepatol 44:520–528

    Article  PubMed  Google Scholar 

  13. Darvish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J, Morard I, Lasser L, Heller J, Hadengue A, Langlet P, Miranda H, Primignani M, Elias E, Leebeek FW, Rosendaal FR, Garcia-Pagan JC, Valla DC, Janssen HL, EN-Vie (European Network for Vascular Disorders of the Liver) (2009) Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 151:167–175

    Google Scholar 

  14. Senzolo M, Cholongitas EC, Patch D, Burroughs AK (2005) Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome. Nat Clin Pract Gastroenterol Hepatol 2:182–190

    Article  PubMed  Google Scholar 

  15. Hadengue A, Poliquin M, Vilgrain V, Belghiti J, Degott C, Erlinger S, Benhamou JP (1994) The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 106:1042–1047

    CAS  PubMed  Google Scholar 

  16. Zeitoun G, Escolano S, Hadengue A, Azar N, Younsi ElM, Mallet A, Boudet MJ, Hay JM, Erlinger S, Benhamou JP, Belghiti J, Valla D (1999) Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 30:84–89

    Article  CAS  PubMed  Google Scholar 

  17. Darvish Murad S, Valla DC, de Groen PC, Zeitoun G, Haagsma EB, Kuipers EJ, Janssen HL (2006) Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol 101:83–90

    Article  Google Scholar 

  18. Kamath P (2006) Budd–Chiari syndrome: radiologic findings. Liver Transp 12:S21–S22

    Article  Google Scholar 

  19. Condat B, Valla D (2006) Nonmalignant portal vein thrombosis in adults. Nat Clin Pract Gastroenterol Hepatol 3:505–515

    Article  PubMed  Google Scholar 

  20. Condat B, Pessione F, Helene Denninger M, Hillaire S, Valla D (2000) Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 32:466–470

    Article  CAS  PubMed  Google Scholar 

  21. Janssen HL, Wijnhoud A, Haagsma EB, van Uum SH, van Nieuwkerk CM, Adang RP, Chamuleau RA, van Hattum J, Vleggaar FP, Hansen BE, Rosendaal FR, van Hoek B (2001) Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 49:720–724

    Article  CAS  PubMed  Google Scholar 

  22. Tessler FN, Gehring BJ, Gomes AS, Perrella RR, Ragavendra N, Busuttil RW, Grant EG (1991) Diagnosis of portal vein thrombosis: value of color Doppler imaging. AJR Am J Roentgenol 157:293–296

    CAS  PubMed  Google Scholar 

  23. Bradbury MS, Kavanagh PV, Chen MY, Weber TM, Bechtold RE (2002) Noninvasive assessment of portomesenteric venous thrombosis: current concepts and imaging strategies. J Comput Assist Tomogr 26:392–404

    Article  PubMed  Google Scholar 

  24. Kumar S, Sarr MG, Kamath PS (2001) Mesenteric vein thrombosis. N Engl J Med 345:1683–1688

    Article  CAS  PubMed  Google Scholar 

  25. Denninger MH, Chaït Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, Briere J, Valla D (2000) Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31:587–591

    Article  CAS  PubMed  Google Scholar 

  26. Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, van Hattum J, Chamuleau RA, Adang RP, Vandenbroucke JP, van Hoek B, Rosendaal FR (2000) Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 96:2364–2368

    CAS  PubMed  Google Scholar 

  27. Primignani M, Barosi G, Bergamaschi G, Gianelli U, Fabris F, Reati R, Dell’Era A, Bucciarelli P, Mannucci PM (2006) Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 44:1528–1534

    Article  CAS  PubMed  Google Scholar 

  28. Plessier A, Darwish Murad S, Hernandez Guerra M, European Network for Vascular Disorders of the Liver (EN-Vie) et al (2009) Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 51:210–218

    Google Scholar 

  29. De Stefano V, Teofili L, Leone G, Michiels JJ (1997) Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 23:411–418

    Article  PubMed  Google Scholar 

  30. Dahabreh IJ, Zoi K, Giannouli S, Zoi C, Loukopoulos D, Voulgarelis M (2009) Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia. Leuk Res 33:67–73

    Article  CAS  PubMed  Google Scholar 

  31. Fiorini A, Chiusolo P, Rossi E, Za T, De Ritis DG, Ciminello A, Leone G, De Stefano V (2009) Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms. Am J Hematol 84:126–127

    Article  PubMed  Google Scholar 

  32. Dentali F, Squizzato A, Brivio L, Appio L, Campiotti L, Crowther M, Grandi AM, Ageno W (2009) JAK2V617F mutation for the early diagnosis of Ph-myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. Blood 113:5617–5623

    Article  CAS  PubMed  Google Scholar 

  33. Marchetti M, Castoldi E, Spronk HM, van Oerle R, Balducci D, Barbui T, Rosing J, Ten Cate H, Falanga A (2008) Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera. Blood 112:4061–4068

    Article  CAS  PubMed  Google Scholar 

  34. Martinelli I, Primignani M, Aghemo A, Reati R, Bucciarelli P, Fabris F, Battaglioli T, Dell’Era A, Mannucci PM (2009) High levels of factor VIII and risk of extra-hepatic portal vein obstruction. J Hepatol 50:916–922

    Article  CAS  PubMed  Google Scholar 

  35. Dentali F, Galli M, Gianni M, Ageno W (2008) Inherited thrombophilic abnormalities and risk of portal vein thrombosis. A meta-analysis. Thromb Haemost 99:675–682

    CAS  PubMed  Google Scholar 

  36. Ziakas PD, Poulou LS, Rokas GI, Bartzoudis D, Voulgarelis M (2007) Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview. J Thromb Haemost 5:642–645

    Article  CAS  PubMed  Google Scholar 

  37. Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M (1997) Budd-Chiari syndrome: a common complication of Behçet’s disease. Am J Gastroenterol 92:858–862

    CAS  PubMed  Google Scholar 

  38. Rautou PE, Plessier A, Bernuau J, Denninger MH, Moucari R, Valla D (2009) Pregnancy: a risk factor for Budd-Chiari syndrome? Gut 58:606–608

    Article  PubMed  Google Scholar 

  39. Valla D, Le MG, Poynard T, Zucman N, Rueff B, Benhamou JP (1986) Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study. Gastroenterology 90:807–811

    CAS  PubMed  Google Scholar 

  40. Stamou KM, Toutouzas KG, Kekis PB, Nakos S, Gafou A, Manouras A, Krespis E, Katsaragakis S, Bramis J (2006) Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg 141:663–669

    Article  PubMed  Google Scholar 

  41. Fimognari FL, Violi F (2008) Portal vein thrombosis in liver cirrhosis. Intern Emerg Med 3:213–218

    Article  PubMed  Google Scholar 

  42. Valla DC (2008) Budd-Chiari syndrome and veno-occlusive disease/sinusoidal obstruction syndrome. Gut 57:1469–1478

    Article  PubMed  Google Scholar 

  43. Plessier A, Sibert A, Consigny Y, Hakime A, Zappa M, Denninger MH, Condat B, Farges O, Chagneau C, de Ledinghen V, Francoz C, Sauvanet A, Vilgrain V, Belghiti J, Durand F, Valla D (2006) Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 44:1308–1316

    Article  PubMed  Google Scholar 

  44. Sharma S, Texeira A, Texeira P, Elias E, Wilde J, Olliff SP (2004) Pharmacological thrombolysis in Budd-Chiari syndrome: a single centre experience and review of the literature. J Hepatol 40:172–180

    Article  CAS  PubMed  Google Scholar 

  45. Smalberg JH, Spaander MV, Jie KS, Pattynama PM, van Buuren HR, van den Berg B, Janssen HL, Leebeek FW (2008) Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis. Thromb Haemost 100:1084–1088

    CAS  PubMed  Google Scholar 

  46. Liu FY, Wang MQ, Fan QS, Duan F, Wang ZJ, Song P (2009) Interventional treatment for symptomatic acute–subacute portal and superior mesenteric vein thrombosis. World J Gastroenterol 15:5028–5034

    Article  PubMed  Google Scholar 

  47. Garcia-Pagán JC, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F, Vizzini G, Abraldes JG, Olliff S, Nicolini A, Luca A, Primignani M, Janssen HL, Valla D, Elias E, Bosch J, Group Budd-Chiari syndrome-transjugular intrahepatic portosystemic shunt (2008) TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 135:808–815

    Article  PubMed  Google Scholar 

  48. Senzolo M, Patch D, Miotto D, Ferronato C, Cholongitas E, Burroughs AK (2008) Interventional treatment should be incorporated in the algorithm for the management of patients with portal vein thrombosis. Hepatology 48:1352–1353

    Article  PubMed  Google Scholar 

  49. Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC, Poliquin M, Hadengue A, Erlinger S, Valla D (2001) Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 120:490–497

    Article  CAS  PubMed  Google Scholar 

  50. Amitrano L, Guardascione MA, Scaglione M, Pezzullo L, Sangiuliano N, Armellino MF, Manguso F, Margaglione M, Ames PR, Iannaccone L, Grandone E, Romano L, Balzano A (2007) Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol 102:2464–2470

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Institute of Hematology, Catholic University, Largo Gemelli 8, 00168, Rome, Italy

    Valerio De Stefano

  2. The A. Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Internal Medicine and Medical Specialities, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy

    Ida Martinelli

Authors
  1. Valerio De Stefano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ida Martinelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Valerio De Stefano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Stefano, V., Martinelli, I. Splanchnic vein thrombosis: clinical presentation, risk factors and treatment. Intern Emerg Med 5, 487–494 (2010). https://doi.org/10.1007/s11739-010-0413-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-010-0413-6

Keywords

Search

Navigation